Mantadix (Amantadine Hydrochloride)

Amantadine blocks the M2 ion channel of influenza A viruses, preventing viral uncoating and replication. It also antagonizes NMDA receptors and stimulates dopamine release in the central nervous system, which helps alleviate Parkinsonian motor symptoms.

The dosage of Mantadix is individualized by the prescribing clinician based on the specific indication, patient age, renal function, and other clinical factors. No standard dose is provided here; the prescriber determines the appropriate regimen.

Safety data for amantadine hydrochloride in pregnancy and lactation are limited. It should only be used when the potential benefit outweighs any possible risk to the fetus or infant, and under close medical supervision.

To request Mantadix, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with neuraminidase inhibitors such as oseltamivir, amantadine targets a different viral protein (M2 ion channel) and is effective primarily against influenza A strains without resistance. In Parkinson's disease, it offers a dopaminergic boost distinct from levodopa, often used as an adjunct rather than a first‑line therapy.

Mantadix should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Mantadix is taken orally, usually with or without food, as directed by the prescriber. Swallow the tablet whole with water; do not crush or chew unless specifically instructed.

Serious adverse reactions include hallucinations, severe skin reactions such as livedo reticularis, and rare cases of neuroleptic malignant syndrome. Patients should seek immediate medical attention if they experience any of these symptoms.

Mantadix is contraindicated in patients with known hypersensitivity to amantadine or any component of the formulation. Caution is advised for individuals with severe renal impairment, uncontrolled cardiac arrhythmias, or active psychosis, and it should be avoided in those where the risk outweighs benefit.